
|Articles|July 19, 2019
July 2019 Digital Edition
Advertisement
With over 1000 measles cases across the US, our July issue’s focus on measles and the antivax movement couldn’t be more timely. Plus, we test your biofilm knowledge and look at the future of AI in pediatric practice.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves centanafadine for ADHD in children, adolescents, and adults
2
Omalizumab outperforms multiallergen oral immunotherapy in multifood allergy trial
3
Garadacimab demonstrates positive results in phase 3b trial for pediatric HAE prophylaxis
4
Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD
5



